SONNSonnet BioTherapeutics Hold...

Nasdaq sonnetbio.com


$ 1.81 $ 0.00 (0 %)    

Tuesday, 14-May-2024 12:13:28 EDT
QQQ $ 452.53 $ 3.62 (0.81 %)
DIA $ 399.31 $ 3.73 (0.94 %)
SPY $ 529.09 $ 3.17 (0.6 %)
TLT $ 92.14 $ 1.28 (1.41 %)
GLD $ 220.89 $ 2.79 (1.28 %)
$ 1.81
$ 1.82
$ 0.00 x 0
$ 0.00 x 0
$ 1.81 - $ 1.82
$ 1.08 - $ 26.40
29,230
na
8.84M
$ 0.75
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 02-14-2024 12-31-2023 10-Q
3 12-14-2023 09-30-2023 10-K
4 08-14-2023 06-30-2023 10-Q
5 05-10-2023 03-31-2023 10-Q
6 02-13-2023 12-31-2022 10-Q
7 12-15-2022 09-30-2022 10-K
8 08-15-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 02-08-2022 12-31-2021 10-Q
11 12-17-2021 09-30-2021 10-K
12 08-16-2021 06-30-2021 10-Q
13 05-17-2021 03-31-2021 10-Q
14 02-16-2021 12-31-2020 10-Q
15 12-17-2020 09-30-2020 10-K
16 08-14-2020 06-30-2020 10-Q
17 05-18-2020 03-31-2020 10-Q
18 03-19-2020 12-31-2019 10-K
19 11-14-2019 09-30-2019 10-Q
20 08-14-2019 06-30-2019 10-Q
21 05-15-2019 03-31-2019 10-Q
22 04-01-2019 12-31-2018 10-K
23 11-14-2018 09-30-2018 10-Q
24 08-13-2018 06-30-2018 10-Q
25 05-15-2018 03-31-2018 10-Q
26 03-30-2018 12-31-2017 10-K
27 11-13-2017 09-30-2017 10-Q
28 08-14-2017 06-30-2017 10-Q
29 05-15-2017 03-31-2017 10-Q
30 03-31-2017 12-31-2016 10-K
31 11-10-2016 09-30-2016 10-Q
32 08-11-2016 06-30-2016 10-Q
33 05-16-2016 03-31-2016 10-Q
34 03-31-2016 12-31-2015 10-K
35 11-16-2015 09-30-2015 10-Q
36 08-14-2015 06-30-2015 10-Q
37 05-20-2015 03-31-2015 10-Q
38 04-15-2015 12-31-2014 10-K
39 11-14-2014 09-30-2014 10-Q
40 08-14-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 sonnet-biotherapeutics-announces-a-publication-demonstrating-safety-and-tolerability-of-son-1010-in-healthy-volunteers

Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a clinical-stage company developing targeted immunotherapeutic drugs for c...

 chardan-capital-maintains-buy-on-sonnet-biotherapeutics-lowers-price-target-to-30

Chardan Capital analyst Keay Nakae maintains Sonnet BioTherapeutics (NASDAQ:SONN) with a Buy and lowers the price target fro...

 sonnet-biotherapeutics-q1-eps-031-may-not-be-comparable-to-090-estimate-sales-1863k-beat-1800k-estimate

Sonnet BioTherapeutics (NASDAQ:SONN) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate o...

 sonnet-biotherapeutics-holdings-inc-files-for-mixed-shelf-of-up-to-100m

– SEC Filing

 ladenburg-thalmann-initiates-coverage-on-sonnet-biotherapeutics-with-buy-rating-announces-price-target-of-7

Ladenburg Thalmann analyst Ahu Demir initiates coverage on Sonnet BioTherapeutics (NASDAQ:SONN) with a Buy rating and announ...

 whats-happening-with-sonnet-biotherapeutics-sonn-shares

Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares are trading lower by 8.5% to $1.18 Thursday morning on downward mom...

 dow-falls-over-100-points-alphabet-shares-tumble-after-q3-results

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling more than 100 points on Wednesday. The Do...

 why-owens-corning-shares-are-trading-lower-by-around-9-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Gainers Abri SPAC I, Inc. (NASDAQ: ASPA) shares climbed 127.1% to $28.39. Abri's stockholders approved its proposed bus...

 crude-oil-edges-higher-thermo-fisher-scientific-cuts-fy23-forecast

U.S. stocks traded mostly lower midway through trading, with the Nasdaq Composite falling more than 150 points on Wednesday. T...

 why-sonnet-biotherapeutics-sonn-stock-is-getting-hammered

Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares are trading lower by 27.6% to $1.31 Wednesday morning after the com...

 nasdaq-down-15-microsoft-posts-upbeat-results

U.S. stocks traded lower this morning, with the Nasdaq Composite falling 1.5% on Wednesday. Following the market opening Wedne...

 why-microsoft-shares-are-trading-higher-here-are-20-stocks-moving-premarket

Gainers ReShape Lifesciences Inc. (NASDAQ: RSLS) shares surged 62.8% to $0.3348 in pre-market trading after gaining over 6% ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION